Spruce Biosciences (SPRBD) Short Interest Ratio & Short Volume

Short interest is the volume of Spruce Biosciences shares that have been sold short but have not yet been covered or closed out. As of August 31st, traders have sold 400 shares of SPRBD short. 0.07% of Spruce Biosciences' shares are currently sold short. Learn More on Spruce Biosciences' current short interest.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.07% of Spruce Biosciences' floating shares are currently sold short.

Spruce Biosciences saw a increase in short interest during the month of August. As of August 31st, there was short interest totaling 400 shares, an increase of 33.3% from the previous total of 300 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

0.07% of Spruce Biosciences' shares are currently sold short. Here is how the short interest of companies in the industry of "biotechnology" compare to Spruce Biosciences: Adial Pharmaceuticals, Inc. (6.84%), Kaleido Biosciences, Inc. (0.17%),

As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($73.23 billion), Invesco QQQ ($29.52 billion), iShares Russell 2000 ETF ($20.82 billion), iShares 20+ Year Treasury Bond ETF ($10.76 billion), Palo Alto Networks, Inc. ($9.37 billion), Strategy Inc ($7.58 billion), Invesco S&P 500 Equal Weight ETF ($6.78 billion), SPDR S&P Biotech ETF ($6.72 billion), AppLovin Corporation ($6.37 billion), and iShares iBoxx $ Investment Grade Corporate Bond ETF ($6.29 billion). View all of the most shorted stocks.

Short selling SPRBD is an investing strategy that aims to generate trading profit from Spruce Biosciences as its price is falling. SPRBD shares are trading up $3.60 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Spruce Biosciences occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of SPRBD, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including SPRBD, twice per month. The most recent reporting period available is August, 31 2025.